The U.S. Food and Drug Administration (FDA) has recorded a regulatory status change for a topical product containing hydrocortisone. The product, identified as HYDROCORTISONE 0.5% OINTMENT (product number 003), is manufactured by Perrigo New York. According to the FDA’s database, the product is classified as a non‑reference drug and is now marked as "Discontinued" under the Abbreviated New Drug Application (ANDA) number ANDA084969. No reference standard is associated with this submission.
Key details:
- Route: Topical
- Dosage form: Ointment
- Active ingredient: Hydrocortisone 0.5%
- Sponsor: Perrigo New York
- Marketing status: Discontinued
- Application number: ANDA084969
Regulatorische Updates28. Sept. 2026•1 Min. Lesezeit
FDA Discontinues Hydrocortisone 0.5% Ointment (ANDA084969)
The FDA has listed the hydrocortisone 0.5% topical ointment (product 003) from Perrigo New York as discontinued under application ANDA084969.
Zusammengestellt vom PharmaCountry-Team · Quelle: FDA.gov
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen